We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-13.53%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.16%
AUM
$4.65B
AUM Growth
-$902M
Cap. Flow
-$55.6M
Cap. Flow %
-1.2%
Top 10 Hldgs %
17.2%
Holding
1,576
New
113
Increased
560
Reduced
639
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 16.34%
2 Healthcare 11.48%
3 Financials 11.22%
4 Industrials 8.07%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BP icon
276
BP
BP
$114B
$3.95M 0.09%
139,286
+4,836
+4% +$148K
CL icon
277
Colgate-Palmolive
CL
$73.1B
$3.94M 0.08%
49,141
-8,867
-15% -$693K
VXF icon
278
Vanguard Extended Market ETF
VXF
$30.8B
$3.93M 0.08%
29,952
+1,949
+7% +$284K
OGN icon
279
Organon & Co
OGN
$3.56B
$3.88M 0.08%
115,025
-2,860
-2% -$100K
VET icon
280
Vermilion Energy
VET
$1.75B
$3.88M 0.08%
+203,550
New +$4.24M
CIBR icon
281
First Trust NASDAQ Cybersecurity ETF
CIBR
$14.6B
$3.86M 0.08%
95,893
-37,365
-28% -$1.67M
INFL icon
282
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.5B
$3.83M 0.08%
134,234
+76,365
+132% +$2.42M
TRV icon
283
Travelers Companies
TRV
$78.1B
$3.83M 0.08%
22,614
+1,462
+7% +$254K
GDX icon
284
VanEck Gold Miners ETF
GDX
$22.9B
$3.8M 0.08%
138,637
+4,708
+4% +$159K
MET icon
285
MetLife
MET
$61.9B
$3.8M 0.08%
60,462
+2,204
+4% +$146K
HUN icon
286
Huntsman Corp
HUN
$1.76B
$3.79M 0.08%
133,509
-30,855
-19% -$1.04M
HACK icon
287
Amplify Cybersecurity ETF
HACK
$2.74B
$3.77M 0.08%
82,237
-1,963
-2% -$98.5K
SWN
288
DELISTED
Southwestern Energy Company
SWN
$3.73M 0.08%
596,585
+204,541
+52% +$1.58M
RDVY icon
289
First Trust Rising Dividend Achievers ETF
RDVY
$25B
$3.72M 0.08%
91,003
+570
+0.6% +$25.8K
WCN
290
Waste Connections
WCN
$42.3B
$3.64M 0.08%
29,357
-1,039
-3% -$135K
GRMN
291
Garmin
GRMN
$58B
$3.61M 0.08%
36,713
-302
-0.8% -$31.8K
TECK icon
292
Teck Resources
TECK
$29.5B
$3.6M 0.08%
117,881
-20,819
-15% -$822K
OLED icon
293
Universal Display
OLED
$3.67B
$3.6M 0.08%
35,585
+1,393
+4% +$179K
VGSH icon
294
Vanguard Short-Term Treasury ETF
VGSH
$29.2B
$3.6M 0.08%
61,129
+52,904
+643% +$3.12M
LMBS icon
295
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.36B
$3.58M 0.08%
74,167
-4,737
-6% -$230K
CI icon
296
Cigna
CI
$74.7B
$3.58M 0.08%
13,563
-800
-6% -$206K
TLT icon
297
iShares 20+ Year Treasury Bond ETF
TLT
$41.4B
$3.57M 0.08%
31,106
-8,766
-22% -$1.03M
MU icon
298
Micron Technology
MU
$920B
$3.57M 0.08%
64,563
+11,124
+21% +$755K
XBI icon
299
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$3.56M 0.08%
47,922
+12,534
+35% +$941K
VCIT icon
300
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$3.56M 0.08%
44,421
+330
+0.7% +$26.9K

Similar funds

Oppenheimer & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Oppenheimer & Co held 1,576 positions worth $4.65B, down 16% from $5.55B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q2 2022 filing shows 113 new, 560 increased, 639 reduced and 173 closed positions. Its largest new stake was Warner Bros: 379,857 shares worth $5.1M. The largest sale was abrdn Physical Gold Shares ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q2 2022 buy was Warner Bros: 379,857 shares worth $5.1M.
  • Oppenheimer & Co added most to State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q2 2022, an estimated $11.4M increase.
  • Oppenheimer & Co's biggest Q2 2022 reduction was Apple, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited abrdn Physical Gold Shares ETF in Q2 2022, selling an estimated $12.8M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.65B portfolio in Q2 2022.
  • Oppenheimer & Co opened 113 new positions and closed 173 in Q2 2022.
  • Oppenheimer & Co's portfolio value fell 16% quarter-over-quarter to $4.65B.

Based on Oppenheimer & Co's 13F filing for Q2 2022, filed 8 Aug 2022.